Study how resistant gut bacteria spread within households
Part of Infections clinical trials.
This study tracks a specific kind of antibiotic-resistant gut bacteria in hospital patients and how it may spread to people living in the same home. It may help researchers understand transmission risk inside households and improve prevention strategies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) hospitalized in one of the participating hospitals
- Your stool test during this hospital stay must show antibiotic-resistant bacteria (MDR-E)
- You must not have had this resistant bacteria in your stool in the past 12 months
- You must live with at least two other household members who agree to join the study
- You must plan to keep living in the Ile de France area for the next 3 months
- Household members must share your home spaces (kitchen and/or bathroom and/or toilets) and also agree
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.
This study looks at how antibiotic-resistant bacteria spread between people and their dogs in the same home. It aims to understand how these germs persist and change over time in humans, animals, and the environment.
This study looks at the types of bacteria in your gut (gut microbiota) by analyzing a stool sample. It aims to better describe typical gut bacteria patterns in France and may help researchers understand links to health.
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
This trial collects wastewater from the hospital building to monitor for drug-resistant germs. It helps researchers understand how resistance spreads in the hospital.
Hear when a new Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.